 Richard Benninger
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 33 | 2025 | 789 | 8.950 |
Why?
| | Insulin-Secreting Cells | 26 | 2025 | 364 | 8.610 |
Why?
| | Gap Junctions | 17 | 2023 | 61 | 5.960 |
Why?
| | Connexins | 11 | 2023 | 51 | 3.390 |
Why?
| | Insulin | 23 | 2024 | 2325 | 2.990 |
Why?
| | Calcium | 16 | 2025 | 1211 | 2.910 |
Why?
| | Calcium Signaling | 12 | 2025 | 250 | 2.810 |
Why?
| | Contrast Media | 5 | 2021 | 393 | 1.820 |
Why?
| | Cell Communication | 6 | 2021 | 300 | 1.790 |
Why?
| | Pancreas | 6 | 2022 | 303 | 1.550 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2023 | 2439 | 1.510 |
Why?
| | Diabetes Mellitus | 6 | 2023 | 1000 | 1.290 |
Why?
| | Glucose | 11 | 2025 | 1000 | 1.210 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2024 | 3628 | 1.160 |
Why?
| | Ultrasonography | 6 | 2022 | 712 | 1.120 |
Why?
| | Mice | 36 | 2025 | 16905 | 1.110 |
Why?
| | Animals | 48 | 2025 | 35286 | 1.080 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2025 | 740 | 1.080 |
Why?
| | Glucokinase | 2 | 2025 | 13 | 0.900 |
Why?
| | Pericytes | 1 | 2022 | 28 | 0.780 |
Why?
| | Cell Membrane | 3 | 2015 | 732 | 0.770 |
Why?
| | Microscopy, Fluorescence | 4 | 2008 | 398 | 0.760 |
Why?
| | Software | 2 | 2025 | 606 | 0.730 |
Why?
| | Mice, Knockout | 11 | 2024 | 2871 | 0.720 |
Why?
| | Protein Kinase C-delta | 2 | 2024 | 44 | 0.710 |
Why?
| | Vagus Nerve | 1 | 2021 | 86 | 0.690 |
Why?
| | Models, Biological | 7 | 2024 | 1722 | 0.660 |
Why?
| | Prediabetic State | 2 | 2020 | 244 | 0.650 |
Why?
| | Algorithms | 3 | 2025 | 1613 | 0.640 |
Why?
| | Caloric Restriction | 1 | 2020 | 111 | 0.630 |
Why?
| | Cytokines | 4 | 2024 | 2012 | 0.620 |
Why?
| | Photons | 3 | 2008 | 64 | 0.610 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2018 | 63 | 0.600 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 183 | 0.540 |
Why?
| | KATP Channels | 2 | 2014 | 20 | 0.530 |
Why?
| | Mice, Inbred NOD | 5 | 2022 | 587 | 0.520 |
Why?
| | Optics and Photonics | 3 | 2013 | 41 | 0.500 |
Why?
| | Fluorescence Polarization | 1 | 2015 | 38 | 0.470 |
Why?
| | Microscopy, Confocal | 3 | 2015 | 305 | 0.460 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2014 | 19 | 0.460 |
Why?
| | Systems Biology | 1 | 2014 | 59 | 0.440 |
Why?
| | Optogenetics | 3 | 2021 | 112 | 0.420 |
Why?
| | Fluorescent Dyes | 3 | 2015 | 312 | 0.400 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 5438 | 0.400 |
Why?
| | Microscopy | 2 | 2013 | 141 | 0.390 |
Why?
| | Microbubbles | 3 | 2021 | 48 | 0.390 |
Why?
| | Cation Transport Proteins | 3 | 2022 | 131 | 0.380 |
Why?
| | Cell Differentiation | 3 | 2018 | 1888 | 0.370 |
Why?
| | Blood Glucose | 7 | 2022 | 2098 | 0.370 |
Why?
| | Mice, SCID | 3 | 2022 | 350 | 0.370 |
Why?
| | Cell Proliferation | 2 | 2018 | 2368 | 0.360 |
Why?
| | Imaging, Three-Dimensional | 4 | 2025 | 527 | 0.360 |
Why?
| | Nitric Oxide | 1 | 2015 | 895 | 0.340 |
Why?
| | Mice, Transgenic | 6 | 2017 | 2117 | 0.340 |
Why?
| | Hyperglycemia | 1 | 2014 | 327 | 0.340 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1220 | 0.330 |
Why?
| | Fluorescence | 5 | 2015 | 155 | 0.330 |
Why?
| | Humans | 29 | 2024 | 129144 | 0.320 |
Why?
| | Immunological Synapses | 1 | 2009 | 16 | 0.310 |
Why?
| | Regional Blood Flow | 2 | 2022 | 463 | 0.300 |
Why?
| | Lasers | 1 | 2008 | 132 | 0.290 |
Why?
| | Cells | 1 | 2008 | 24 | 0.290 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 66 | 0.280 |
Why?
| | Membrane Potentials | 3 | 2025 | 292 | 0.270 |
Why?
| | Aging | 1 | 2017 | 1774 | 0.270 |
Why?
| | Microfluidics | 1 | 2007 | 52 | 0.260 |
Why?
| | Homeostasis | 3 | 2022 | 605 | 0.250 |
Why?
| | Zinc | 3 | 2019 | 285 | 0.250 |
Why?
| | Killer Cells, Natural | 1 | 2009 | 426 | 0.240 |
Why?
| | Coloring Agents | 2 | 2021 | 77 | 0.240 |
Why?
| | Nanotechnology | 1 | 2006 | 121 | 0.230 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 132 | 0.230 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2024 | 38 | 0.230 |
Why?
| | Palate | 1 | 2024 | 35 | 0.230 |
Why?
| | Zinc Transporter 8 | 3 | 2022 | 87 | 0.230 |
Why?
| | Spectrum Analysis | 1 | 2004 | 89 | 0.220 |
Why?
| | Spectrometry, Fluorescence | 1 | 2004 | 163 | 0.220 |
Why?
| | NADP | 2 | 2017 | 46 | 0.220 |
Why?
| | Mesoderm | 1 | 2024 | 137 | 0.220 |
Why?
| | Neural Crest | 1 | 2024 | 114 | 0.220 |
Why?
| | Tamoxifen | 2 | 2022 | 195 | 0.210 |
Why?
| | Caspase 3 | 1 | 2024 | 245 | 0.210 |
Why?
| | In Vitro Techniques | 2 | 2017 | 1085 | 0.200 |
Why?
| | Cholesterol | 1 | 2004 | 412 | 0.200 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2023 | 160 | 0.200 |
Why?
| | Cells, Cultured | 5 | 2014 | 4075 | 0.200 |
Why?
| | Verapamil | 1 | 2022 | 41 | 0.190 |
Why?
| | Superoxide Dismutase | 2 | 2014 | 342 | 0.190 |
Why?
| | Perfusion | 1 | 2022 | 197 | 0.180 |
Why?
| | Choline O-Acetyltransferase | 1 | 2021 | 22 | 0.180 |
Why?
| | Optical Imaging | 1 | 2021 | 56 | 0.180 |
Why?
| | Cholinergic Fibers | 1 | 2021 | 17 | 0.180 |
Why?
| | Channelrhodopsins | 1 | 2021 | 16 | 0.180 |
Why?
| | Cholinergic Neurons | 1 | 2021 | 16 | 0.180 |
Why?
| | Vagus Nerve Stimulation | 1 | 2021 | 30 | 0.180 |
Why?
| | Biomimetics | 1 | 2021 | 42 | 0.170 |
Why?
| | Equipment Design | 3 | 2015 | 512 | 0.170 |
Why?
| | Embryonic Stem Cells | 1 | 2021 | 114 | 0.170 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 161 | 0.170 |
Why?
| | Boron Compounds | 2 | 2015 | 22 | 0.170 |
Why?
| | Early Diagnosis | 1 | 2021 | 233 | 0.170 |
Why?
| | Glucagon | 1 | 2021 | 105 | 0.170 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 216 | 0.170 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2020 | 34 | 0.170 |
Why?
| | Electrophysiological Phenomena | 1 | 2020 | 54 | 0.170 |
Why?
| | Animals, Newborn | 2 | 2014 | 834 | 0.170 |
Why?
| | DNA | 1 | 2007 | 1396 | 0.170 |
Why?
| | Electrophysiology | 1 | 2020 | 210 | 0.160 |
Why?
| | Homeodomain Proteins | 2 | 2021 | 493 | 0.160 |
Why?
| | Axons | 1 | 2021 | 191 | 0.160 |
Why?
| | Recombinant Proteins | 2 | 2015 | 1304 | 0.160 |
Why?
| | Diet, High-Fat | 1 | 2020 | 239 | 0.150 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 221 | 0.150 |
Why?
| | Phospholipids | 1 | 2020 | 215 | 0.150 |
Why?
| | Potassium Channels, Inwardly Rectifying | 2 | 2024 | 36 | 0.140 |
Why?
| | Cell Line, Tumor | 3 | 2014 | 3186 | 0.140 |
Why?
| | Paracrine Communication | 1 | 2018 | 61 | 0.140 |
Why?
| | Cations, Divalent | 1 | 2017 | 53 | 0.140 |
Why?
| | Transcriptome | 2 | 2021 | 874 | 0.140 |
Why?
| | Biological Clocks | 1 | 2017 | 40 | 0.140 |
Why?
| | Nerve Tissue Proteins | 1 | 2021 | 569 | 0.140 |
Why?
| | Glucose Tolerance Test | 3 | 2014 | 355 | 0.130 |
Why?
| | Tissue Banks | 1 | 2015 | 15 | 0.130 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1678 | 0.120 |
Why?
| | Tissue Culture Techniques | 1 | 2015 | 74 | 0.120 |
Why?
| | Single-Cell Analysis | 1 | 2018 | 274 | 0.120 |
Why?
| | Transcription, Genetic | 1 | 2021 | 1416 | 0.120 |
Why?
| | Apoptosis | 1 | 2024 | 2491 | 0.120 |
Why?
| | Evolution, Molecular | 1 | 2019 | 464 | 0.120 |
Why?
| | Oxygen | 1 | 2020 | 914 | 0.120 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2015 | 31 | 0.120 |
Why?
| | Calibration | 1 | 2015 | 140 | 0.110 |
Why?
| | Maf Transcription Factors, Large | 1 | 2014 | 6 | 0.110 |
Why?
| | Enzyme Activation | 1 | 2015 | 812 | 0.110 |
Why?
| | Time Factors | 5 | 2014 | 6541 | 0.110 |
Why?
| | Female | 7 | 2021 | 68494 | 0.110 |
Why?
| | Autoantibodies | 1 | 2021 | 1467 | 0.110 |
Why?
| | Immunotherapy | 1 | 2018 | 590 | 0.110 |
Why?
| | Interleukin-1beta | 1 | 2015 | 372 | 0.110 |
Why?
| | Exocytosis | 1 | 2014 | 88 | 0.110 |
Why?
| | Computer Simulation | 1 | 2017 | 937 | 0.100 |
Why?
| | Diagnostic Imaging | 2 | 2007 | 325 | 0.100 |
Why?
| | Male | 7 | 2025 | 63456 | 0.100 |
Why?
| | Hypertension, Pulmonary | 2 | 2014 | 1894 | 0.100 |
Why?
| | Cell Survival | 1 | 2015 | 1074 | 0.100 |
Why?
| | Interferon-gamma | 1 | 2015 | 772 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 827 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2020 | 1165 | 0.100 |
Why?
| | Cyclic AMP | 1 | 2011 | 237 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4056 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1201 | 0.090 |
Why?
| | Disease Progression | 1 | 2018 | 2622 | 0.090 |
Why?
| | GTP-Binding Protein alpha Subunits | 1 | 2010 | 14 | 0.090 |
Why?
| | Models, Theoretical | 1 | 2014 | 546 | 0.090 |
Why?
| | Cytoplasmic Vesicles | 1 | 2009 | 13 | 0.080 |
Why?
| | Dimethylpolysiloxanes | 1 | 2009 | 9 | 0.080 |
Why?
| | Glycosylphosphatidylinositols | 1 | 2009 | 11 | 0.080 |
Why?
| | Transplantation, Heterotopic | 1 | 2008 | 18 | 0.080 |
Why?
| | Receptors, KIR2DL1 | 1 | 2009 | 18 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2009 | 179 | 0.080 |
Why?
| | Electricity | 1 | 2008 | 18 | 0.080 |
Why?
| | HLA-C Antigens | 1 | 2009 | 35 | 0.080 |
Why?
| | Cell Line, Transformed | 1 | 2009 | 141 | 0.080 |
Why?
| | Pancreas Transplantation | 1 | 2008 | 75 | 0.080 |
Why?
| | Scattering, Radiation | 1 | 2008 | 100 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3705 | 0.080 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2009 | 72 | 0.070 |
Why?
| | NAD | 1 | 2008 | 75 | 0.070 |
Why?
| | Gene Knockout Techniques | 1 | 2008 | 109 | 0.070 |
Why?
| | Cell Physiological Phenomena | 1 | 2008 | 17 | 0.070 |
Why?
| | Embryo, Mammalian | 2 | 2024 | 224 | 0.070 |
Why?
| | Protein Interaction Mapping | 1 | 2008 | 108 | 0.070 |
Why?
| | Hypoxia | 1 | 2014 | 1084 | 0.070 |
Why?
| | Proteins | 1 | 2013 | 941 | 0.070 |
Why?
| | Cell Membrane Structures | 1 | 2006 | 6 | 0.070 |
Why?
| | Protein Engineering | 1 | 2008 | 106 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2059 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 3963 | 0.070 |
Why?
| | Microchip Analytical Procedures | 1 | 2006 | 5 | 0.060 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2008 | 175 | 0.060 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2006 | 36 | 0.060 |
Why?
| | Energy Transfer | 1 | 2006 | 49 | 0.060 |
Why?
| | Cattle | 1 | 2008 | 977 | 0.060 |
Why?
| | Microelectrodes | 1 | 2025 | 42 | 0.060 |
Why?
| | Phagocytosis | 1 | 2006 | 362 | 0.060 |
Why?
| | Microscopy, Video | 1 | 2004 | 25 | 0.060 |
Why?
| | Anisotropy | 1 | 2004 | 73 | 0.060 |
Why?
| | bcl-2-Associated X Protein | 1 | 2024 | 55 | 0.060 |
Why?
| | Diffusion | 1 | 2004 | 116 | 0.060 |
Why?
| | Nanotubes | 1 | 2004 | 43 | 0.060 |
Why?
| | Cytological Techniques | 1 | 2004 | 26 | 0.060 |
Why?
| | Burkitt Lymphoma | 1 | 2004 | 56 | 0.060 |
Why?
| | Cleft Palate | 1 | 2024 | 57 | 0.050 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2025 | 211 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 262 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1033 | 0.050 |
Why?
| | Temperature | 1 | 2006 | 635 | 0.050 |
Why?
| | Haploinsufficiency | 1 | 2022 | 48 | 0.050 |
Why?
| | Respiration | 1 | 2022 | 191 | 0.050 |
Why?
| | Action Potentials | 1 | 2025 | 485 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1833 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2004 | 497 | 0.050 |
Why?
| | Lipids | 1 | 2004 | 625 | 0.040 |
Why?
| | Models, Statistical | 1 | 2004 | 623 | 0.040 |
Why?
| | Surface-Active Agents | 1 | 2021 | 84 | 0.040 |
Why?
| | Bacteria | 1 | 2006 | 813 | 0.040 |
Why?
| | Signal Transduction | 3 | 2024 | 4919 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 191 | 0.040 |
Why?
| | Lung | 3 | 2021 | 3927 | 0.040 |
Why?
| | Computational Biology | 1 | 2024 | 596 | 0.040 |
Why?
| | Macrophages | 1 | 2006 | 1481 | 0.040 |
Why?
| | Cell Line | 1 | 2004 | 2775 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 2272 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3077 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2536 | 0.030 |
Why?
| | GTP Cyclohydrolase | 1 | 2014 | 8 | 0.030 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.030 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 22 | 0.030 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 35 | 0.030 |
Why?
| | Estrogen Antagonists | 1 | 2014 | 45 | 0.030 |
Why?
| | Adult | 1 | 2017 | 35469 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2014 | 90 | 0.030 |
Why?
| | Sepharose | 1 | 2014 | 33 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2014 | 145 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 203 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 165 | 0.030 |
Why?
| | Neoplasms | 1 | 2008 | 2442 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 328 | 0.030 |
Why?
| | Arginine | 1 | 2014 | 263 | 0.030 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 217 | 0.030 |
Why?
| | Heparin | 1 | 2014 | 253 | 0.030 |
Why?
| | Kidney | 1 | 2020 | 1384 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 644 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 776 | 0.020 |
Why?
| | Antioxidants | 1 | 2014 | 558 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2668 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1833 | 0.020 |
Why?
| | Printing | 1 | 2009 | 4 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2014 | 820 | 0.020 |
Why?
| | Streptozocin | 1 | 2008 | 20 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2014 | 1095 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 946 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 389 | 0.020 |
Why?
| | Convallaria | 1 | 2007 | 1 | 0.020 |
Why?
| | Blood Pressure | 1 | 2014 | 1736 | 0.020 |
Why?
| | Transport Vesicles | 1 | 2006 | 18 | 0.020 |
Why?
| | Mice, Nude | 1 | 2008 | 682 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2009 | 336 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2014 | 2699 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 569 | 0.020 |
Why?
| | Biological Transport | 1 | 2006 | 403 | 0.020 |
Why?
| | Arteries | 1 | 2007 | 265 | 0.010 |
Why?
| | Actins | 1 | 2006 | 411 | 0.010 |
Why?
| | Microtubules | 1 | 2006 | 263 | 0.010 |
Why?
| | Skin | 1 | 2008 | 726 | 0.010 |
Why?
| | Cell Movement | 1 | 2006 | 944 | 0.010 |
Why?
| | Endoscopy | 1 | 2004 | 285 | 0.010 |
Why?
| | Risk Factors | 1 | 2014 | 9740 | 0.010 |
Why?
| | Pregnancy | 1 | 2008 | 6392 | 0.010 |
Why?
|
|
Benninger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|